Valuation Vineet Laboratories Limited

Stocks

Delayed NSE India S.E. 22:57:05 2026-11-08 EST			5-day change	1st Jan Change
38.54 ^INR	+4.05%		+6.79%	+4.79%

10-26	Vineet Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
08-25	Vineet Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025
Market Cap ¹	439.3	381.7	446.2	287.6
Change	-	-13.12%	16.91%	-35.54%
Enterprise Value (EV) ¹	523.3	686.2	886.9	685
Change	-	31.15%	29.24%	-22.76%
P/E	6.62x	30.5x	43.6x	-1.42x
PBR	1.32x	1.13x	1.28x	1.96x
PEG	0x	-0.4x	-2.4x	0x
Capitalization / Revenue	229,785x	179,783x	295,567x	373,778x
EV / Revenue	-	-	-	-
EV / EBITDA	-	-	-	-
EV / EBIT	4.66x	12.2x	17.5x	-4.07x
EV / FCF	-	-	-	-
FCF Yield	-	-	-	-
Dividend per Share ²	1	-	-	-
Rate of return	2.1%	-	-	-
EPS ²	7.201	1.359	1.11	-21.9
Distribution rate	13.9%	-	-	-
Net sales	1,912	2,123	1,510	769.5
EBITDA	132.4	79.97	74.27	-143.3
EBIT ¹	112.3	56.24	50.54	-168.3
Net income ¹	66.39	12.52	10.27	-201.9
Net Debt ¹	83.97	304.6	440.7	397.4
Reference price ²	47.65	41.40	48.40	31.20
Nbr of stocks (in thousands)	9,219	9,219	9,219	9,219
Announcement Date	9/5/22	9/5/23	9/4/24	9/2/25

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
VINEET LABORATORIES LIMITED	-	-	-	-	7.57M
ELI LILLY AND COMPANY	39.62x	13.42x	28.51x	0.5%	1,206B
JOHNSON & JOHNSON	40.43x	6.79x	19.09x	1.93%	665B
ABBVIE INC.	37.52x	8.51x	17.57x	2.38%	515B
ROCHE HOLDING AG	20.98x	5.12x	12.74x	2.57%	381B
MERCK & CO., INC.	97.18x	5.94x	25.33x	2.32%	362B
NOVARTIS AG	23.18x	5.95x	14.36x	2.69%	307B
ASTRAZENECA PLC	24.46x	4.89x	13.77x	1.79%	289B
AMGEN INC.	23.75x	7.3x	13.55x	2.19%	249B
GILEAD SCIENCES, INC.	-39.18x	7.28x	45.82x	1.98%	207B
Average	29.77x	7.24x	21.19x	2.04%	417.98B
Weighted average by Cap.	35.67x	8.55x	21.86x	1.73%